Medicine and Dentistry
Child
100%
Patient
72%
Glucose Tolerance
66%
Liver
44%
Vitamin D
44%
Oral Glucose Tolerance Test
44%
Liver Disease
44%
Kidney Stone
44%
Ivacaftor
44%
Tezacaftor
44%
Diabetes
22%
Age
18%
Complication
11%
Nutritional Status
11%
Lung
11%
Shear Wave Elastography
11%
Pediatrics
10%
Male
8%
Female
8%
Stone
8%
Spirometry
5%
Measurement
5%
Biopsy
5%
Indicator
5%
Retrospective Cohort Study
5%
Impaired Glucose Tolerance
5%
Liver Cirrhosis
5%
Non Invasive Procedure
5%
Adolescent
5%
Cystic Fibrosis Transmembrane Conductance Regulator
5%
Lung Clearance
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cystic Fibrosis
44%
Prevalence
44%
Ivacaftor
44%
Tezacaftor
44%
Stone Formation
8%
Urinalysis
8%
Hematuria
8%
Clinical Feature
8%
Cystic Fibrosis Transmembrane Conductance Regulator
5%
